Roger Jeffs, CEO of Liquidia Corp (NASDAQ:LQDA), sold a total of 75,000 shares of common stock for approximately $4.58 million across three transactions between May 21 and May 26, 2026.
The shares were sold at volume-weighted average prices ranging from $60.3784 to $61.5222 per share under a Rule 10b5-1 trading plan adopted on November 5, 2025.
The sales come as Liquidia shares trade near their 52-week high of $62.30, following a 292% return over the past year. The stock closed at $60.09, giving the company a market cap of $5.35 billion.
Following the transactions, Mr. Jeffs directly holds 1,137,508 shares, including various unvested restricted stock units (RSUs). He also holds 46,595 shares indirectly through the Roger A. Jeffs Living Trust and 1,048,095 shares through Serendipity BioPharma LLC.
In other recent news, Liquidia Technologies reported Q1 revenue of $130 million, beating consensus estimates. Strong sales of Yutrepia have caught analyst attention, with firms like H.C. Wainwright, Raymond James, Wells Fargo, Jefferies, and BTIG raising price targets.
